1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Beijing Tongrentang Co., Ltd
  6. Summary
    600085   CNE000000R69

BEIJING TONGRENTANG CO., LTD

(600085)
  Report
End-of-day quote Shanghai Stock Exchange  -  05-15
42.54 CNY   +1.48%
04/29Beijing Tongrentang Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
03/25Beijing Tongrentang Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2021Beijing Tongrentang Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
05/10/2022 05/11/2022 05/12/2022 05/13/2022 05/16/2022 Date
40.25 40.32 40.88 41.92 42.54 Last
9955694 14203950 7960933 10724240 14922790 Volume
+0.45% +0.17% +1.39% +2.54% +1.48% Change
Estimated financial data (e)
Sales 2022 16 756 M 2 470 M 2 470 M
Net income 2022 1 475 M 217 M 217 M
Net cash position 2022 4 839 M 713 M 713 M
P/E ratio 2022 39,5x
Yield 2022 1,07%
Sales 2023 18 865 M 2 781 M 2 781 M
Net income 2023 1 801 M 265 M 265 M
Net cash position 2023 7 250 M 1 069 M 1 069 M
P/E ratio 2023 32,9x
Yield 2023 1,17%
Capitalization 58 342 M 8 599 M 8 599 M
EV / Sales 2022 3,19x
EV / Sales 2023 2,71x
Nbr of Employees 18 997
Free-Float 45,7%
More Financials
Company
BEIJING TONGRENTANG CO., LTD is a China-based company principally engaged in the production and sales of traditional Chinese patent medicines. The CompanyÔÇÖs main products consist of liuwei dihuang series, tongren dahuoluo series, tongren niuhuang qingxin series, angong niuhuang series and donkey-hide gelatin series. The Company distributes its products under the brand of Tongrentang. The Company is also involved... 
Sector
Pharmaceuticals
Calendar
08/30Earnings Release
More about the company
Ratings of Beijing Tongrentang Co., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about BEIJING TONGRENTANG CO., LTD
04/29Beijing Tongrentang Co., Ltd Reports Earnings Results for the First Quarter Ended March..
CI
03/25Beijing Tongrentang Co., Ltd Reports Earnings Results for the Full Year Ended December ..
CI
2021Beijing Tongrentang Co., Ltd Reports Earnings Results for the Nine Months Ended Septemb..
CI
2021Beijing Tongrentang Co., Ltd Reports Earnings Results for the Half Year Ended June 30, ..
CI
2021China stocks end lower as healthcare, tech firms tumble
RE
2021China stocks fall on healthcare slump; Hong Kong down
RE
2021Beijing Tongrentang Co., Ltd Reports Earnings Results for the First Quarter Ended March..
CI
2021Beijing Tongrentang Co., Ltd Reports Earnings Results for the Full Year Ended December ..
CI
2020BEIJING TONGRENTANG CO., LTD(XSSC : 600085) dropped from S&P Global BMI Index
CI
2020BEIJING TONGRENTANG CO., LTD(SHSE : 600085) dropped from Shanghai Stock Exchange 180 Value..
CI
2020BEIJING TONGRENTANG CO., LTD(XSSC : 600085) dropped from FTSE All-World Index
CI
2020BEIJING TONGRENTANG CO., LTD(SHSE : 600085) dropped from SSE 180 Index
CI
2020Beijing Tongrentang Co., Ltd Reports Earnings Results for the Nine Months Ended Septemb..
CI
2020Beijing Tongrentang Co., Ltd Reports Earnings Results for the Half Year Ended June 30, ..
CI
2020Beijing Tongrentang Co., Ltd. Announces Cash Dividend for 2019, Payable July 20, 2020
CI
More news
News in other languages on BEIJING TONGRENTANG CO., LTD
04/29Beijing Tongrentang Co., Ltd. annonce ses résultats financiers pour le premier trimestr..
03/25Beijing Tongrentang Co., Ltd. annonce ses résultats pour l'année complète se terminant ..
2020Beijing Tongrentang Co., Ltd. annonce un dividende en espèces pour 2019, payable le 20 ..
More news
Chart BEIJING TONGRENTANG CO., LTD
Duration : Period :
Beijing Tongrentang Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIJING TONGRENTANG CO., LTD
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 42,54 CNY
Average target price 46,36 CNY
Spread / Average Target 8,98%
EPS Revisions
Managers and Directors
De Ying Hou General Manager
Shu Bing Di Chairman
Fu Guo Mao Chairman-Supervisory Board
Yuan Liu Independent Director
Ying Wang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BEIJING TONGRENTANG CO., LTD-5.42%8 470
JOHNSON & JOHNSON3.38%465 363
PFIZER, INC.-15.46%280 096
ABBVIE INC.13.37%271 251
ELI LILLY AND COMPANY5.58%262 514
ROCHE HOLDING AG-15.85%258 421